“FDA Greenlights GSK’s Revolutionary RSV Vaccine for Senior Citizens”
“FDA Greenlights GSK’s Revolutionary RSV Vaccine for Senior Citizens” FDA Greenlights GSK’s Revolutionary RSV Vaccine for Senior Citizens After a long journey, GlaxoSmithKline (GSK) gets the green light from the US FDA for their revolutionary vaccine targeting the respiratory syncytial virus (RSV), which affects older patients, especially those aged 65 and up. This significant milestone … Read more